Back to Search Start Over

Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone app.

Authors :
Oldroyd AGS
Krogh NS
Dixon WG
Chinoy H
Source :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 Nov 28; Vol. 61 (12), pp. 4845-4854.
Publication Year :
2022

Abstract

Objective: The objective of this study was to use daily data collected via a smartphone app for characterization of patient-reported and symptom-based (using an a priori definition) flares in an adult idiopathic inflammatory myopathy (IIM) cohort.<br />Methods: UK adults with an IIM answered patient-reported outcome measurements (PROMs) daily via a smartphone app during a 91-day study. Daily symptom PROMs addressed global activity, overall pain, myalgia, fatigue, and weakness (on a 0-100 visual analogue scale). Patient-reported flares were recorded via a weekly app question. Symptom-based flares were defined via an a priori definition related to increase in daily symptom data from the previous 4-day mean.<br />Results: Twenty participants (65% female) participated. Patient-reported flares occurred on a median of 5 weeks (IQR 3, 7) per participant, out of a possible 13. The mean of each symptom score was significantly higher in flare weeks, compared with non-flare weeks (e.g. mean flare week myalgia score 34/100, vs 21/100 during non-flare week, t test P-value <0.01). Fatigue accounted for the most symptom-based flares [incidence-rate 23/100 person-days (95% CI 19, 27)], and myalgia the fewest [incidence rate 13/100 person-days (95% CI 11, 16)]. Symptom-based flares typically resolved after 3 days, although fatigue-predominant flares lasted 2 days. The majority (69%) of patient-reported flare weeks coincided with at least one symptom-based flare.<br />Conclusions: IIM flares are frequent and associated with increased symptom scores. This study has demonstrated the ability to identify and characterize patient-reported and symptom-based flares (based on an a priori definition), using daily app-collected data.<br /> (© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology.)

Details

Language :
English
ISSN :
1462-0332
Volume :
61
Issue :
12
Database :
MEDLINE
Journal :
Rheumatology (Oxford, England)
Publication Type :
Academic Journal
Accession number :
35274670
Full Text :
https://doi.org/10.1093/rheumatology/keac161